Clinical and demographic characteristics of the study individuals
Patient ID . | Sex . | Age, y . | Ethnicity . | Time since HIV-1 diagnosis, mo. . | CD4+ T-cell count/μL . | HIV-1 RNA load, coples/mL . | HLA class I type . | Peptides tested . |
---|---|---|---|---|---|---|---|---|
AC-04 | M | 41 | White | 69 | 398 | 14 400 | A2, 11; B18, 44; Cw5, 12 | A11-AK9 (Nef) (AVDLSHFLK) |
A11-AK9 (RT) (AIFQSSMTK) | ||||||||
A11-QVK9 (QIYAGIKVK) | ||||||||
A11-KK11 (KTKPPLPSVKK) | ||||||||
B44-AW11 (AEQASQDVKNW) | ||||||||
AC-14 | M | 49 | White | 53 | 500 | 3 650 | A2, 3; B8, 62; Cw7, 10 | A3-RK11 (RMRGAHTNDVK) |
A2-IV9 (ILKEPVHGV) | ||||||||
A3-RK9 (RLRPGGKKK) | ||||||||
A3-RK10 (RIRTWKSLVK) | ||||||||
B8-EI8 (EIYKRWII) | ||||||||
B8-FL8 (FLKEKGGL) | ||||||||
AC-02 | M | 48 | White | 72 | 706 | 269 | A11, 29; B8, 44; Cw4, 7 | B8-EI8 (EIYKRWII) |
B8-FL8 (FLKEKGGL) | ||||||||
B8-EV9 (ELRSLYNTV) | ||||||||
A11-AK11 (ACQGVGGPGHK) | ||||||||
B44-AY9 (AENLWVTVY) | ||||||||
AC-16 | M | 40 | White | 51 | 1049 | 56 700 | A28, 29; B14, 44; Cw8 | A29-SY9 (SFEPIPIHY) |
A29-SY10 (SFNCGGEFFY) | ||||||||
B14-DA9 (DRFYKTLRA) | ||||||||
B14-CC9 (CRAPRKKGC) | ||||||||
B14-EL9 (ERYLKDQQL) | ||||||||
B44-AW11 (AEQASQDVKNW) | ||||||||
AC-06 | M | 42 | White | 54 | 542 | 51 800 | A3; B7; Cw7 | B7-SM9 (SPAIFQSSM) |
B7-GL9 (GPGHKARVL) | ||||||||
B7-TL9 (TPQDLNTML) | ||||||||
B7-HA9 (HPVHAGPVA) | ||||||||
B7-HI10 (HPRISSEVHI) | ||||||||
B7-HKI10 (HPKISSEVHI) | ||||||||
A3-KK10 (KLVDFRELNK) | ||||||||
A3-GK9 (GIPHPAGLK) | ||||||||
A3-RK10 (RIRTWKSLVK) | ||||||||
CO-06 | M | 50 | White | 92 | 672 | 1 200 | A25, 32; B8, 14; Cw7, 8 | B8-EI8 (EIYKRWII) |
B8-FL8 (FLKEKGGL) | ||||||||
B8-GL9 (GPKVKQWPL) | ||||||||
Cw8-KL10 (KAAVDLSHFL) | ||||||||
B14-DA9 (DRFYKTLRA) | ||||||||
B14-EL9 (ERYLKDQQL) | ||||||||
AC-05 | M | 43 | White | 62 | 387 | 14 100 | A3; B14, 60; Cw3, 7 | A3-ATK9 (AIFQSSMTK) |
B14-DA9 (DRFYKTLRA) | ||||||||
A3-QK10 (QVPLRPMTYK) | ||||||||
A3-KK9 (KIRLRPGGK) | ||||||||
A3-AK9 (AVDLSHFLK) | ||||||||
B40-KL10 (KEKGGLEGL) | ||||||||
FW-003 | M | 41 | White | 36 | 649 | 4 180 | A1, 3; B8, 14; Cw7, 8 | B8-EI8 (EIYKRWII) |
B8-FL8 (FLKEKGGL) | ||||||||
A3-QK10 (QVPLRPMTYK) | ||||||||
A3-ATK9 (AIFQSSMTK) | ||||||||
A3-RK9 (RLRPGGKKK) | ||||||||
B8-DL9 (DCKTILKAL) | ||||||||
B8-GL8 (GGKKKYKL) | ||||||||
FW-009 | M | 43 | White | 37 | 322 | 68 880 | A31, 68; B7, 70; Cw7, 1 | B7-TL10 (TPGPGVRYPL) |
B7-IL9 (IPRRIRQGL) | ||||||||
A68-DL9 (DTVLEEMNL) |
Patient ID . | Sex . | Age, y . | Ethnicity . | Time since HIV-1 diagnosis, mo. . | CD4+ T-cell count/μL . | HIV-1 RNA load, coples/mL . | HLA class I type . | Peptides tested . |
---|---|---|---|---|---|---|---|---|
AC-04 | M | 41 | White | 69 | 398 | 14 400 | A2, 11; B18, 44; Cw5, 12 | A11-AK9 (Nef) (AVDLSHFLK) |
A11-AK9 (RT) (AIFQSSMTK) | ||||||||
A11-QVK9 (QIYAGIKVK) | ||||||||
A11-KK11 (KTKPPLPSVKK) | ||||||||
B44-AW11 (AEQASQDVKNW) | ||||||||
AC-14 | M | 49 | White | 53 | 500 | 3 650 | A2, 3; B8, 62; Cw7, 10 | A3-RK11 (RMRGAHTNDVK) |
A2-IV9 (ILKEPVHGV) | ||||||||
A3-RK9 (RLRPGGKKK) | ||||||||
A3-RK10 (RIRTWKSLVK) | ||||||||
B8-EI8 (EIYKRWII) | ||||||||
B8-FL8 (FLKEKGGL) | ||||||||
AC-02 | M | 48 | White | 72 | 706 | 269 | A11, 29; B8, 44; Cw4, 7 | B8-EI8 (EIYKRWII) |
B8-FL8 (FLKEKGGL) | ||||||||
B8-EV9 (ELRSLYNTV) | ||||||||
A11-AK11 (ACQGVGGPGHK) | ||||||||
B44-AY9 (AENLWVTVY) | ||||||||
AC-16 | M | 40 | White | 51 | 1049 | 56 700 | A28, 29; B14, 44; Cw8 | A29-SY9 (SFEPIPIHY) |
A29-SY10 (SFNCGGEFFY) | ||||||||
B14-DA9 (DRFYKTLRA) | ||||||||
B14-CC9 (CRAPRKKGC) | ||||||||
B14-EL9 (ERYLKDQQL) | ||||||||
B44-AW11 (AEQASQDVKNW) | ||||||||
AC-06 | M | 42 | White | 54 | 542 | 51 800 | A3; B7; Cw7 | B7-SM9 (SPAIFQSSM) |
B7-GL9 (GPGHKARVL) | ||||||||
B7-TL9 (TPQDLNTML) | ||||||||
B7-HA9 (HPVHAGPVA) | ||||||||
B7-HI10 (HPRISSEVHI) | ||||||||
B7-HKI10 (HPKISSEVHI) | ||||||||
A3-KK10 (KLVDFRELNK) | ||||||||
A3-GK9 (GIPHPAGLK) | ||||||||
A3-RK10 (RIRTWKSLVK) | ||||||||
CO-06 | M | 50 | White | 92 | 672 | 1 200 | A25, 32; B8, 14; Cw7, 8 | B8-EI8 (EIYKRWII) |
B8-FL8 (FLKEKGGL) | ||||||||
B8-GL9 (GPKVKQWPL) | ||||||||
Cw8-KL10 (KAAVDLSHFL) | ||||||||
B14-DA9 (DRFYKTLRA) | ||||||||
B14-EL9 (ERYLKDQQL) | ||||||||
AC-05 | M | 43 | White | 62 | 387 | 14 100 | A3; B14, 60; Cw3, 7 | A3-ATK9 (AIFQSSMTK) |
B14-DA9 (DRFYKTLRA) | ||||||||
A3-QK10 (QVPLRPMTYK) | ||||||||
A3-KK9 (KIRLRPGGK) | ||||||||
A3-AK9 (AVDLSHFLK) | ||||||||
B40-KL10 (KEKGGLEGL) | ||||||||
FW-003 | M | 41 | White | 36 | 649 | 4 180 | A1, 3; B8, 14; Cw7, 8 | B8-EI8 (EIYKRWII) |
B8-FL8 (FLKEKGGL) | ||||||||
A3-QK10 (QVPLRPMTYK) | ||||||||
A3-ATK9 (AIFQSSMTK) | ||||||||
A3-RK9 (RLRPGGKKK) | ||||||||
B8-DL9 (DCKTILKAL) | ||||||||
B8-GL8 (GGKKKYKL) | ||||||||
FW-009 | M | 43 | White | 37 | 322 | 68 880 | A31, 68; B7, 70; Cw7, 1 | B7-TL10 (TPGPGVRYPL) |
B7-IL9 (IPRRIRQGL) | ||||||||
A68-DL9 (DTVLEEMNL) |